1Department of Community Medicine, Institute of Health and Society, University of Oslo, Oslo, Norway.
2Executive Diabetes Care Centre, NHN, Diabetic Association of Bangladesh, Dhaka, Bangladesh.
3Department of Biochemistry & Cell Biology, Bio-Medical Research Group, Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders (BIRDEM), Dhaka, Bangladesh.
4Diabetes Prevention Intervention Project, Diabetic Association of Bangladesh, Dhaka, Bangladesh.
5Institute of Statistical Research and Training, University of Dhaka, Dhaka, Bangladesh.
6Department of Endocrinology, Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders (BIRDEM), Dhaka, Bangladesh.
Copyright © 2012 Korean Diabetes Association
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Values are presented as % (number) or (95% confidence interval) as indicated. Age adjustment was based on 2001 census of Bangladesh.
T2DM, type 2 diabetes mellitus; IFG, impaired fasting glucose; IGT, impaired glucose tolerance.
aχ2 trend=P<0.05 for T2DM and IFG, bP<0.05 compared with male in the same glucose tolerance group.
Values are presented as % (95% confidence interval) adjusted for age.
IFG, impaired fasting glucose; IGT, impaired glucose tolerance; DM, diabetes mellitus; BMI, body mass index; WHR, waist hip ratio; HTN, hypertension; BP, blood pressure; TG, triglycerides; HDL-C, high density lipoprotein cholesterol; MADRS, Montogomery-Asberg Depression Rating Scale; F/H DM, family history of diabetes.
aP<0.05, bP<0.001 compared with male in the same glucose tolerance group.
Values are presented as mean (95% confidence interval) adjusted for age or geometric mean (95% confidence interval).
NGT, normal glucose tolerance; IFG, impaired fasting glucose; IGT, impaired glucose tolerance; DM, diabetes mellitus; BMI, body mass index; WHR, waist hip ratio; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; TG, triglyceride; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; FBG, fasting blood glucose; 2hPG, 2-hour plasma glucose; FPI, fasting plasma insulin; HOMA-B, homeostasis model assessment of β-cell function; HOMA-IR, homeostasis model assessment of insulin resistance.
aGeometric mean (95% confidence interval), bP<0.05, cP<0.001 compared with male in the same glucose tolerance group.
OR, odds ratio; CI, confidence interval; IFG, impaired fasting glucose; IGT, impaired glucose tolerance; BMI, body mass index; WHR, waist hip ratio; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; TG, triglyceride; HDL-C, high density lipoprotein cholesterol; MADRS, Montogomery-Asberg Depression Rating Scale.
Values are presented as % (number) or (95% confidence interval) as indicated. Age adjustment was based on 2001 census of Bangladesh. T2DM, type 2 diabetes mellitus; IFG, impaired fasting glucose; IGT, impaired glucose tolerance. aχ2 trend=
Values are presented as % (95% confidence interval) adjusted for age. IFG, impaired fasting glucose; IGT, impaired glucose tolerance; DM, diabetes mellitus; BMI, body mass index; WHR, waist hip ratio; HTN, hypertension; BP, blood pressure; TG, triglycerides; HDL-C, high density lipoprotein cholesterol; MADRS, Montogomery-Asberg Depression Rating Scale; F/H DM, family history of diabetes. a
Values are presented as mean (95% confidence interval) adjusted for age or geometric mean (95% confidence interval). NGT, normal glucose tolerance; IFG, impaired fasting glucose; IGT, impaired glucose tolerance; DM, diabetes mellitus; BMI, body mass index; WHR, waist hip ratio; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; TG, triglyceride; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; FBG, fasting blood glucose; 2hPG, 2-hour plasma glucose; FPI, fasting plasma insulin; HOMA-B, homeostasis model assessment of β-cell function; HOMA-IR, homeostasis model assessment of insulin resistance. aGeometric mean (95% confidence interval), b
Values are presented as number (%). FPG, fasting plasma glucose; 2hPG, 2-hour plasma glucose; NGT, normal glucose tolerance; IFG, impaired fasting glucose; IGT, impaired glucose tolerance; DM, diabetes mellitus.
OR, odds ratio; CI, confidence interval; IFG, impaired fasting glucose; IGT, impaired glucose tolerance; BMI, body mass index; WHR, waist hip ratio; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; TG, triglyceride; HDL-C, high density lipoprotein cholesterol; MADRS, Montogomery-Asberg Depression Rating Scale.